Bayshore Asset Management’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$553K Hold
1,393
0.2% 31
2026
Q1
$242K Buy
1,393
+1
+0.1% +$205 0.1% 39
2025
Q4
$357K Hold
1,392
0.15% 33
2025
Q3
$362K Hold
1,392
0.16% 32
2025
Q2
$340K Hold
1,392
0.16% 34
2025
Q1
$368K Hold
1,392
0.18% 30
2024
Q4
$353K Hold
1,392
0.16% 41
2024
Q3
$441K Hold
1,392
0.2% 40
2024
Q2
$520K Hold
1,392
0.26% 25
2024
Q1
$483K Hold
1,392
0.24% 27
2023
Q4
$637K Hold
1,392
0.34% 24
2023
Q3
$677K Hold
1,392
0.4% 24
2023
Q2
$636K Hold
1,392
0.35% 26
2023
Q1
$676K Hold
1,392
0.4% 23
2022
Q4
$713K Hold
1,392
0.46% 19
2022
Q3
$675K Hold
1,392
0.51% 19
2022
Q2
$652K Hold
1,392
0.47% 19
2022
Q1
$606K Hold
1,392
0.44% 19
2021
Q4
$646K Buy
+1,392
New +$616K 0.47% 13

Other funds holding HUM

Bayshore Asset Management's HUM Position: Q2 2026 in Review

Bayshore Asset Management held its Humana (HUM) position steady in Q2 2026 at 1,393 shares worth $553K. The position accounts for 0.2% of the portfolio, ranked #31.

Bayshore Asset Management first reported a position in HUM in Q4 2021 and has held it in 19 quarters since. The position peaked at $713K in Q4 2022. 924 funds tracked by Wall St. Rank hold HUM as of Q2 2026.

  • Bayshore Asset Management held 1,393 shares of Humana worth $553K as of Q2 2026.
  • Bayshore Asset Management left its Humana share count unchanged in Q2 2026.
  • Humana made up 0.2% of Bayshore Asset Management's portfolio in Q2 2026, its #31 holding.
  • Bayshore Asset Management first reported a position in Humana in Q4 2021 and has held it in 19 quarters since.
  • Bayshore Asset Management's Humana position peaked at $713K in Q4 2022.
  • 924 funds tracked by Wall St. Rank held Humana as of Q2 2026.

Based on Bayshore Asset Management's 13F filing for Q2 2026, filed 23 Jul 2026.